Literature DB >> 20610874

Effect of chondroitin sulfate-E on the osteoclastic differentiation of RAW264 cells.

Tatsuya Miyazaki1, Satoshi Miyauchi, Akira Tawada, Takahisa Anada, Osamu Suzuki.   

Abstract

The present study was designed to investigate whether chondroitin sulfate (CS)-E, a CS structural isomer variant, alter the differentiation of macrophage cell line RAW264 cells to osteoclast-like cells. CS-B, CS-E, low molecular weight CS-E, synthetic chondroitin polysulfate (CPS) and heparin significantly inhibited the formation of tartrate-resistant acid phosphatase-positive multinuclear cells and pit formation on calcium phosphate (CaP)-coated plates. CS-E pre-coated on the CaP plate also inhibited pit formation. Digestion of CS on the cell surface by chondroitinase showed no effect on the osteoclastic differentiation of RAW264 cells whereas inhibitory effect on the differentiation of osteoblastic cell line MC3T3-E1. On the other hand, exogenously added fluorescein-labeled CS-E directory bound to fibronectin and RAW264 cells. These results suggest that CS-E structure on the surface of osteoblasts or bone matrix binds to cell adhesion molecule such as integrin on the pre-osteoclastic cells and inhibits the differentiation into osteoclasts. CS-E may have a potential in treating bone defect if combined with CaP materials.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20610874     DOI: 10.4012/dmj.2009-132

Source DB:  PubMed          Journal:  Dent Mater J        ISSN: 0287-4547            Impact factor:   2.102


  6 in total

Review 1.  Regenerative potential of glycosaminoglycans for skin and bone.

Authors:  Juliane Salbach; Tilman D Rachner; Martina Rauner; Ute Hempel; Ulf Anderegg; Sandra Franz; Jan-Christoph Simon; Lorenz C Hofbauer
Journal:  J Mol Med (Berl)       Date:  2011-12-21       Impact factor: 4.599

2.  Sulfated Glucuronorhamnoxylan from Capsosiphon fulvescens Ameliorates Osteoporotic Bone Resorption via Inhibition of Osteoclastic Cell Differentiation and Function In Vitro and In Vivo.

Authors:  Seong Cheol Kim; Hyeon Jeong Kim; Gi Eun Park; Chang Won Lee; Andriy Synytsya; Peter Capek; Yong Il Park
Journal:  Mar Biotechnol (NY)       Date:  2022-07-07       Impact factor: 3.727

3.  Comparison of the ability of chondroitin sulfate derived from bovine, fish and pigs to suppress human osteoclast activity in vitro.

Authors:  M D Cantley; K D Rainsford; D R Haynes
Journal:  Inflammopharmacology       Date:  2013-05-04       Impact factor: 4.473

4.  Differential growth factor adsorption to calvarial osteoblast-secreted extracellular matrices instructs osteoblastic behavior.

Authors:  Archana Bhat; Simeon A Boyadjiev; Craig W Senders; J Kent Leach
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

5.  Diamond squid (Thysanoteuthis rhombus)-derived chondroitin sulfate stimulates bone healing within a rat calvarial defect.

Authors:  Yoshinao Z Hosaka; Yuji Iwai; Jun-ichi Tamura; Masato Uehara
Journal:  Mar Drugs       Date:  2013-12-11       Impact factor: 5.118

6.  Sodium-dependent phosphate transporters in osteoclast differentiation and function.

Authors:  Giuseppe Albano; Matthias Moor; Silvia Dolder; Mark Siegrist; Carsten A Wagner; Jürg Biber; Nati Hernando; Willy Hofstetter; Olivier Bonny; Daniel G Fuster
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.